Book Value Per Share: The amount of equity available to shareholders expressed on a per common share basis. Calculated as: Total Shareholders Equity / Common Shares Outstanding
Vivos Therapeutics, Inc. (VVOS) had Book Value Per Share of $-0.09 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$5.14M |
|
$-7.68M |
|
$2.08M |
|
$3.06M |
|
$11.76M |
|
$-6.62M |
|
$-1.14M |
|
$-7.75M |
|
$-7.75M |
|
$-7.75M |
|
$-7.75M |
|
$-7.75M |
|
$-7.75M |
|
$-6.62M |
|
$-6.16M |
|
14.63M |
|
14.63M |
|
$-0.52 |
|
$-0.52 |
|
| Balance Sheet Financials | |
$4.82M |
|
$3.53M |
|
$20.22M |
|
$25.04M |
|
$17.94M |
|
$0.42M |
|
$8.37M |
|
$26.31M |
|
$-1.01M |
|
$-13.68M |
|
$-1.27M |
|
13.49M |
|
| Cash Flow Statement Financials | |
$-6.01M |
|
$-0.02M |
|
$6.11M |
|
$2.03M |
|
$2.11M |
|
$0.08M |
|
$0.67M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.27 |
|
-- |
|
-- |
|
-0.49 |
|
-6.09 |
|
59.50% |
|
-128.67% |
|
-128.67% |
|
-- |
|
-150.77% |
|
-149.43% |
|
$-6.03M |
|
-- |
|
-- |
|
-- |
|
0.21 |
|
-- |
|
2.91 |
|
30.97 |
|
768.19% |
|
56.67% |
|
-30.95% |
|
912.96% |
|
|
Book Value Per Share |
$-0.09 |
$-0.41 |
|
$-0.41 |
|